Alto Neuroscience Inc.
ANRO Real Time Price USDRecent trades of ANRO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ANRO's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
ANRO Revenue by Segment or Geography
New patents grants
-
Patent Title: Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agent Feb. 25, 2025
-
Patent Title: Method of treatment and selection of patients benefiting from agomelatine based on eeg measurements Feb. 18, 2025
-
Patent Title: Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agent Jan. 28, 2025
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ANRO
Recent picks made for ANRO stock on CNBC
ETFs with the largest estimated holdings in ANRO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ANRO stock a Buy, Sell, or Hold?
- What is the price target for $ANRO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ANRO stock?
- Who owns the most shares of $ANRO stock?
- What funds own $ANRO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ANRO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.